Fox Business - The Power to Prosper
Search Site

Barr Pharmaceuticals

Long-Term Bull Run Ahead for the Markets?

Hays Advisory Chairman Don Hays on why investors will see a bull market over the next year.

Read More

  1. Generic Drug Deal

    Barr Pharmaceuticals CEO, Bruce Downey talks about the company being bought by Teva Pharmaceuticals

  2. Factors of a Sustained Rally

    David Darst Morgan Stanley Global Wealth Management, discusses the factors to look for that indicate a sustained rally, such as the price of gold and inflation.

  3. Options Activity in 2008

    Michael McCarty, Meridian Equity Partners Inc., discusses the option activity of 2008 and why his perdictions were so accurate.

  4. Teva Beats Out Valeant in $6.8B Cephalon Bid

    Topping a bid by rival Valeant (NYSE:VRX), Teva Pharmaceutical (NASDAQ:TEVA) has inked a deal to acquire Cephalon (NASDAQ:CEPH) for $6.8 billion in an effort to buil...

  5. Options Activity in 2008

    McCarty on his accurate 2008 predictions.

  6. Factors of a Sustained Rally

    What are the factors of a sustained rally?

Freebase CC-BY
Source: Barr Pharmaceuticals on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL